vs
Side-by-side financial comparison of FGI Industries Ltd. (FGI) and Karyopharm Therapeutics Inc. (KPTI). Click either name above to swap in a different company.
Karyopharm Therapeutics Inc. is the larger business by last-quarter revenue ($34.1M vs $30.5M, roughly 1.1× FGI Industries Ltd.). FGI Industries Ltd. runs the higher net margin — -8.6% vs -299.9%, a 291.3% gap on every dollar of revenue. On growth, Karyopharm Therapeutics Inc. posted the faster year-over-year revenue change (11.6% vs -14.4%). Over the past eight quarters, Karyopharm Therapeutics Inc.'s revenue compounded faster (1.4% CAGR vs -0.5%).
FGI Industries Ltd is a global designer, manufacturer and distributor of kitchen and bath products, home organization solutions, and home improvement goods. It serves major retail chains, home specialty stores and e-commerce platforms across North America, Europe and the Asia-Pacific region.
FGI vs KPTI — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $30.5M | $34.1M |
| Net Profit | $-2.6M | $-102.2M |
| Gross Margin | 26.7% | — |
| Operating Margin | -2.2% | -52.4% |
| Net Margin | -8.6% | -299.9% |
| Revenue YoY | -14.4% | 11.6% |
| Net Profit YoY | -553.1% | -232.0% |
| EPS (diluted) | $-1.63 | $-7.02 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $30.5M | $34.1M | ||
| Q3 25 | $35.8M | $44.0M | ||
| Q2 25 | $31.0M | $37.9M | ||
| Q1 25 | $33.2M | $30.0M | ||
| Q4 24 | $35.6M | $30.5M | ||
| Q3 24 | $36.1M | $38.8M | ||
| Q2 24 | $29.4M | $42.8M | ||
| Q1 24 | $30.8M | $33.1M |
| Q4 25 | $-2.6M | $-102.2M | ||
| Q3 25 | $-1.7M | $-33.1M | ||
| Q2 25 | $-1.2M | $-37.3M | ||
| Q1 25 | $-629.1K | $-23.5M | ||
| Q4 24 | $-402.3K | $-30.8M | ||
| Q3 24 | $-550.1K | $-32.1M | ||
| Q2 24 | $163.6K | $23.8M | ||
| Q1 24 | $-412.2K | $-37.4M |
| Q4 25 | 26.7% | — | ||
| Q3 25 | 26.5% | — | ||
| Q2 25 | 28.1% | — | ||
| Q1 25 | 26.8% | — | ||
| Q4 24 | 24.6% | — | ||
| Q3 24 | 25.8% | — | ||
| Q2 24 | 30.5% | — | ||
| Q1 24 | 27.4% | — |
| Q4 25 | -2.2% | -52.4% | ||
| Q3 25 | 1.0% | -34.6% | ||
| Q2 25 | -2.7% | -64.3% | ||
| Q1 25 | -3.9% | -110.8% | ||
| Q4 24 | -3.5% | -102.4% | ||
| Q3 24 | -0.2% | -67.8% | ||
| Q2 24 | -1.5% | -65.7% | ||
| Q1 24 | -1.0% | -101.9% |
| Q4 25 | -8.6% | -299.9% | ||
| Q3 25 | -4.6% | -75.2% | ||
| Q2 25 | -4.0% | -98.2% | ||
| Q1 25 | -1.9% | -78.2% | ||
| Q4 24 | -1.1% | -100.8% | ||
| Q3 24 | -1.5% | -82.7% | ||
| Q2 24 | 0.6% | 55.6% | ||
| Q1 24 | -1.3% | -112.8% |
| Q4 25 | $-1.63 | $-7.02 | ||
| Q3 25 | $-0.86 | $-3.82 | ||
| Q2 25 | $-0.64 | $-4.32 | ||
| Q1 25 | $-0.07 | $-2.77 | ||
| Q4 24 | $-0.38 | $-2.33 | ||
| Q3 24 | $-0.29 | $-3.85 | ||
| Q2 24 | $0.08 | $-2.97 | ||
| Q1 24 | $-0.04 | $-4.85 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $1.9M | $60.5M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $17.3M | $-292.9M |
| Total Assets | $69.5M | $108.4M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $1.9M | $60.5M | ||
| Q3 25 | $1.9M | $37.7M | ||
| Q2 25 | $2.5M | $38.7M | ||
| Q1 25 | $1.2M | $38.8M | ||
| Q4 24 | $4.6M | $62.5M | ||
| Q3 24 | $3.0M | $72.8M | ||
| Q2 24 | $1.3M | $84.8M | ||
| Q1 24 | $3.3M | $30.6M |
| Q4 25 | $17.3M | $-292.9M | ||
| Q3 25 | $19.7M | $-269.3M | ||
| Q2 25 | $21.3M | $-238.9M | ||
| Q1 25 | $21.8M | $-205.9M | ||
| Q4 24 | $22.3M | $-186.0M | ||
| Q3 24 | $23.5M | $-159.6M | ||
| Q2 24 | $23.8M | $-132.1M | ||
| Q1 24 | $23.9M | $-169.0M |
| Q4 25 | $69.5M | $108.4M | ||
| Q3 25 | $73.0M | $96.2M | ||
| Q2 25 | $71.7M | $104.9M | ||
| Q1 25 | $68.5M | $127.7M | ||
| Q4 24 | $75.5M | $164.4M | ||
| Q3 24 | $74.7M | $189.5M | ||
| Q2 24 | $69.9M | $214.0M | ||
| Q1 24 | $68.6M | $204.5M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $2.3M | $-11.8M |
| Free Cash FlowOCF − Capex | $2.3M | — |
| FCF MarginFCF / Revenue | 7.5% | — |
| Capex IntensityCapex / Revenue | 0.2% | 0.0% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $-212.5K | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $2.3M | $-11.8M | ||
| Q3 25 | $-1.9M | $-5.9M | ||
| Q2 25 | $7.6M | $-18.7M | ||
| Q1 25 | $-7.4M | $-39.0M | ||
| Q4 24 | $617.4K | $-25.8M | ||
| Q3 24 | $-915.0K | $-19.5M | ||
| Q2 24 | $862.1K | $-38.5M | ||
| Q1 24 | $-8.0M | $-43.7M |
| Q4 25 | $2.3M | — | ||
| Q3 25 | $-2.1M | — | ||
| Q2 25 | $7.4M | — | ||
| Q1 25 | $-7.7M | — | ||
| Q4 24 | $-214.1K | $-25.9M | ||
| Q3 24 | $-1.1M | — | ||
| Q2 24 | $281.5K | — | ||
| Q1 24 | $-8.6M | $-43.9M |
| Q4 25 | 7.5% | — | ||
| Q3 25 | -5.9% | — | ||
| Q2 25 | 23.8% | — | ||
| Q1 25 | -23.3% | — | ||
| Q4 24 | -0.6% | -84.7% | ||
| Q3 24 | -3.0% | — | ||
| Q2 24 | 1.0% | — | ||
| Q1 24 | -28.0% | -132.6% |
| Q4 25 | 0.2% | 0.0% | ||
| Q3 25 | 0.7% | 0.0% | ||
| Q2 25 | 0.7% | 0.0% | ||
| Q1 25 | 1.1% | 0.0% | ||
| Q4 24 | 2.3% | 0.2% | ||
| Q3 24 | 0.5% | 0.0% | ||
| Q2 24 | 2.0% | 0.0% | ||
| Q1 24 | 2.0% | 0.6% |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | 5.27× | -1.62× | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
FGI
| Sanitaryware | $19.1M | 63% |
| Shower System | $5.8M | 19% |
| Kitchen And Bath Other | $3.3M | 11% |
| Bath Furniture Products | $2.3M | 7% |
KPTI
| Products | $32.1M | 94% |
| License And Other | $2.0M | 6% |
